7.4 Common Traps in Mental Health Disorders

7.4 Common Traps in Mental Health Disorders

Most wrong answers in this domain come from accepting a psychiatric label too quickly or from confusing look-alike conditions. Learn the discriminating cues.

Trap 1: Hallucination type

Auditory hallucinations are the hallmark of primary psychiatric illness (schizophrenia, psychotic mood disorders). Visual, tactile, or olfactory hallucinations point toward a medical/toxic cause — delirium, withdrawal, intoxication, seizure, or a CNS lesion. A patient "seeing things" with abnormal vitals is medical until proven otherwise.

Trap 2: Treating withdrawal as agitation

Alcohol withdrawal progresses from tremor, anxiety, and tachycardia within hours, to withdrawal seizures (6–48 hours), to delirium tremens (DTs) at 48–96 hours. DTs present with autonomic storm — hyperthermia, tachycardia, hypertension, diaphoresis, profound confusion, and hallucinations — and can be fatal. The CIWA-Ar scale grades severity once withdrawal is diagnosed (it is not a diagnostic test and is not used in frank delirium). The correct treatment is benzodiazepines (symptom-triggered), which restore GABA tone.

Antipsychotics alone are a trap: they lower the seizure threshold, do not treat the underlying GABA deficit, and risk neuroleptic malignant syndrome.

Trap 3: Panic attack as a diagnosis of exclusion

A panic attack brings chest pain, palpitations, dyspnea, paresthesias, and a sense of impending doom — symptoms identical to MI, pulmonary embolism, arrhythmia, hypoglycemia, and thyroid storm. The trap is labeling a first-time "panic" patient as anxious without an ECG, glucose, and cardiopulmonary assessment. Anxiety is the answer only after medical causes are excluded.

Medication toxidromes and mood-disorder traps

Lithium toxicity

Lithium has a narrow therapeutic window. Early toxicity causes coarse tremor, GI upset, and weakness; worsening toxicity adds ataxia, slurred speech, confusion, seizures, and dysrhythmias. Dehydration, NSAIDs, ACE inhibitors, thiazide diuretics, and renal impairment raise levels. Management is fluids and, for severe cases, hemodialysis — not more lithium.

Serotonin syndrome vs. neuroleptic malignant syndrome (NMS)

These two are a classic pairing:

Clonus and hyperreflexia favor serotonin syndrome; lead-pipe rigidity favors NMS. Both are treated by stopping the offending drug, aggressive cooling, and supportive care.

Mood-disorder traps

Mania (bipolar I) brings elevated/irritable mood, grandiosity, decreased need for sleep, pressured speech, flight of ideas, and risk-taking; severe mania can include psychotic features (grandiose delusions). Psychotic depression can also include delusions and hallucinations, usually mood-congruent themes of guilt or worthlessness. So the presence of psychosis does not by itself name the pole — you read the mood and behavior. A depressed patient who suddenly becomes calm and energized after deciding to die may be at higher risk, not lower; do not read improved affect as safety.

Trap checklist

• Visual/tactile hallucination → think medical.
• Withdrawal → benzodiazepines, not antipsychotics.
• First-time panic → rule out MI/PE/glucose first.
• Tremor + ataxia + confusion on lithium → suspect toxicity.
• Rigidity vs. clonus → NMS vs. serotonin syndrome.

Acute dystonia and other antipsychotic effects

Antipsychotics also cause extrapyramidal symptoms that the nurse must recognize and not mistake for worsening psychosis. Acute dystonia (torticollis, oculogyric crisis, laryngospasm) appears within hours to days and is reversed with diphenhydramine or benztropine. Akathisia is intense motor restlessness easily confused with agitation; the wrong move is to give more antipsychotic. Tardive dyskinesia is a late, often irreversible movement disorder. A patient given haloperidol who develops a stiff, twisted neck has dystonia and needs an anticholinergic, not more sedation — a frequently tested distinction.

Toxic ingestions in the despairing patient

Intentional overdose blurs the line between behavioral and medical care. Two high-yield ingestions: acetaminophen overdose may be silent for the first 24 hours yet cause fatal hepatotoxicity, so a measured acetaminophen level and the Rumack-Matthew nomogram guide N-acetylcysteine; and tricyclic antidepressant overdose causes a widened QRS, anticholinergic toxidrome, seizures, and dysrhythmias treated with sodium bicarbonate. Always screen the suicidal patient for co-ingestants and check acetaminophen and salicylate levels even when the patient names a different drug, because reported histories are unreliable.

The unifying lesson of this section: a behavioral diagnosis never excuses skipping the medical workup, and recognizing the medication toxidrome is often what saves the patient.

Stimulant and opioid overlaps

Two more substance traps round out the differential. Stimulant intoxication (cocaine, methamphetamine, MDMA) produces agitation, hypertension, tachycardia, hyperthermia, dilated pupils, and chest pain; benzodiazepines are first-line for the agitation and the sympathetic surge, and beta-blockers are avoided in cocaine toxicity because of the unopposed alpha-stimulation concern.

Opioid overdose causes the opposite picture — depressed level of consciousness, pinpoint pupils, and respiratory depression reversed with naloxone, while opioid withdrawal (yawning, lacrimation, piloerection, GI cramping, anxiety) is miserable but not life-threatening. A frequent trap is sedating an agitated stimulant patient as if it were a simple psychiatric crisis while missing the hyperthermia and acidosis that can kill them, so the nurse treats the physiology, not just the behavior.

The throughline of this whole section is pattern recognition: pupils, vital signs, onset, and the drug history reclassify a "behavioral" patient into the correct medical emergency.